Vitamin D3 for Life

Live Enlightened

Research libraryVitamin D3 For Life
Study design and methods

Secondary relevance to vitamin D This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.

This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.

Why this paper is included

Supporting source evidence:

Most literature reported an increase in tau levels (2 increase vs 1 not significant), homocysteine levels (4 increase), vitamin D deficiency (3 increase), low bone mineral density (1 increase vs 1 inconsistent), low magnesium levels (1 increase vs 1 inconsistent), and white matter hyperintensities (2 increase vs 1 inconsistent) are associated with an increased risk of AD/ADRD.

Source: AD/ADRD risk factors in RWD literature. View original paper

Relevance classification does not establish study quality, causation or editorial approval.

Study design Review / evidence synthesis.

Review / evidence synthesis

Reviews existing research; the exact review methods need further assessment.

Meta-analysis reported · Blinding not applicable to this review · Research setting awaiting verification

How this paper was classified

Automatic source-based classification; awaiting editorial verification. This is not a quality score.

In our study, we summarized the risk factors for AD/ADRD by reviewing existing meta-analyses and review articles on risk and preventive factors for AD/ADRD.

Source: Abstract.

Publisher article type: review-article

Source: Publisher publication metadata.

View supporting evidence in the original paper

What the study types mean
Systematic review
Uses explicit methods to identify, assess and summarise research on a defined question.
Scoping review
Maps the extent and characteristics of research on a topic.
Narrative review
Discusses existing research; systematic-review methods have not been established by this classification.
Review / evidence synthesis
Reviews existing research; the exact review methods need further assessment.
Randomised controlled trial
Assigns participants or groups to comparison interventions by chance.
Non-randomised intervention study
Examines an intervention without random allocation.
Cohort study
Examines exposures and outcomes over time within a defined group.
Case-control study
Compares people with an outcome against people without it, examining exposures.
Cross-sectional study
Examines a population at a particular point in time.
Observational study
Observes exposures and outcomes without assigning the exposure; the subtype is not established here.
Case report
Describes an individual case.
Case series
Describes a group of individual cases.
Secondary analysis
Analyses existing study data; this paper is not automatically another independent trial.
Laboratory study
Investigates biological processes in a laboratory setting.
Qualitative study
Examines experiences or meanings using qualitative methods.
Genetic instrumental-variable study
Uses genetic variation as an instrument to investigate relationships; this is not a randomised treatment trial.
Study protocol
Describes planned methods and is not evidence that the planned study has reported results.
Multiple reported designs
More than one design is explicitly reported; examine the supporting methods.
Study design awaiting verification
The available source does not establish a sufficiently clear study design.

Meta-analysis combines numerical results from studies. Blinding describes who was unaware of treatment allocation. Neither is a separate quality grade. Study design, vitamin D relevance and document format are independent filters.

Abstracts

Feasibility of identifying factors related to Alzheimer’s disease and related dementia in real-world data

Review / evidence synthesis · JAMIA Open · 2026

Original publication title

Feasibility of identifying factors related to Alzheimer’s disease and related dementia in real-world data

Yu Huang; Qian Li; Aokun Chen; Yongqiu Li; Yu-Neng Chuang; Xia Hu; Serena Jingchuan Guo; Xing He; Yijiang Pang; Jiayu Zhou; Yonghui Wu; Yi Guo; Jiang Bian

© The Author(s) 2026. Published by Oxford University Press on behalf of the American Medical Informatics Association.

Original publication · Publisher record · CC BY 4.0

Source wording retained. Formatting, section navigation and display-title punctuation adapted for this research record.

Authors’ conclusion

Most factors, including conditions, medications, biomarkers, and procedures, are accessible from structured EHRs. For those not accessible from structured EHRs, clinical narratives serve as promising sources of information. However, evaluating genomic factors using RWD remains to be a challenge, possibly due to the fact that genetic testing for AD/ADRD is still uncommon and poorly documented in both structured and unstructured EHRs. Considering the continuously and rapidly evolving research on AD/ADRD, automated literature mining via natural language processing (NLP) methods offers a way to automatically update our knowledge graph.

An extract from the source publication. Read it in context.

At a glance

Abstract: What objectives does the paper state?

This study aimed to provide a comprehensive understanding of factors associated with Alzheimer’s disease (AD) and AD-related dementias (AD/ADRD), which could aid in studies to develop new treatments for AD/ADRD patients and identify high-risk populations for prevention.

Source: Objective

Abstract: Scope and Method

In our study, we summarized the risk factors for AD/ADRD by reviewing existing meta-analyses and review articles on risk and preventive factors for AD/ADRD. From this literature review and the identified AD/ADRD factors, we examined the accessibility of these risk and preventive factors in both structured and unstructured Electronic Health Records (EHRs) data.

Source: Scope and Method

Abstract: Results

In total, we extracted 401 factors in 10 categories from the identified studies. To share our findings, we created an interactive knowledge graph of these risk factors and the relationships among them to assist in the design of future AD/ADRD studies that aim to use large collections of real-world data (RWD) to generate real-world evidence (RWE).

Source: Results

Abstract: Discussion and Conclusion

Most factors, including conditions, medications, biomarkers, and procedures, are accessible from structured EHRs. For those not accessible from structured EHRs, clinical narratives serve as promising sources of information. However, evaluating genomic factors using RWD remains to be a challenge, possibly due to the fact that genetic testing for AD/ADRD is still uncommon and poorly documented in both structured and unstructured EHRs. Considering the continuously and rapidly evolving research on AD/ADRD, automated literature mining via natural language processing (NLP) methods offers a way to automatically update our knowledge graph.

Source: Discussion and Conclusion
Authors’ abstract

Abstract

Objective

This study aimed to provide a comprehensive understanding of factors associated with Alzheimer’s disease (AD) and AD-related dementias (AD/ADRD), which could aid in studies to develop new treatments for AD/ADRD patients and identify high-risk populations for prevention.

Scope and Method

In our study, we summarized the risk factors for AD/ADRD by reviewing existing meta-analyses and review articles on risk and preventive factors for AD/ADRD. From this literature review and the identified AD/ADRD factors, we examined the accessibility of these risk and preventive factors in both structured and unstructured Electronic Health Records (EHRs) data.

Results

In total, we extracted 401 factors in 10 categories from the identified studies. To share our findings, we created an interactive knowledge graph of these risk factors and the relationships among them to assist in the design of future AD/ADRD studies that aim to use large collections of real-world data (RWD) to generate real-world evidence (RWE).

Discussion and Conclusion

Most factors, including conditions, medications, biomarkers, and procedures, are accessible from structured EHRs. For those not accessible from structured EHRs, clinical narratives serve as promising sources of information. However, evaluating genomic factors using RWD remains to be a challenge, possibly due to the fact that genetic testing for AD/ADRD is still uncommon and poorly documented in both structured and unstructured EHRs. Considering the continuously and rapidly evolving research on AD/ADRD, automated literature mining via natural language processing (NLP) methods offers a way to automatically update our knowledge graph.

Publication and source details

Original title: Feasibility of identifying factors related to Alzheimer’s disease and related dementia in real-world data

Yu Huang; Qian Li; Aokun Chen; Yongqiu Li; Yu-Neng Chuang; Xia Hu; Serena Jingchuan Guo; Xing He; Yijiang Pang; Jiayu Zhou; Yonghui Wu; Yi Guo; Jiang Bian

JAMIA Open · 2026

Corresponding author: Jiang Bian, PhD, Department of Biostatistics and Health Data Science, School of Medicine, Indiana University, USA, HITS 3000, BSAT, Indianapolis, IN 46202, United States (bianji@iu.edu, ji0ng.bi0n@gmail.com)
†

Yu Huang, Qian Li and Aokun Chen Co-first, contributed equally

© The Author(s) 2026. Published by Oxford University Press on behalf of the American Medical Informatics Association.2026https://creativecommons.org/licenses/by/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited. National Institute of Health R01AG089445U01AG088076R01AG083039RF1AG084178R01AG084236RF1AG077820R01AG080991R01AG080624R01AG076234

Repository JATS snapshot; version as supplied

Source retrieved: 2026-11-10T23:21:08.925332+00:00

DOI: 10.1093/jamiaopen/ooag060 · PMC13108722